Krystal Biotech, Inc.Krystal Biotech, Inc.Krystal Biotech, Inc.

Krystal Biotech, Inc.

No trades
See on Supercharts

KRYS fundamentals

Krystal Biotech, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of KRYS for the last quarter is 45.25 M USD, and it's 7.37% higher compared to the previous quarter. The net income of Q1 24 is 932.00 k USD.

Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth